Alzheimers

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

July 15, 2023 Matthew Perrone, Associated Press

WASHINGTON, D.C. — U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing […]

Alzheimer’s drug stirs hope for patients, worry for doctors

July 6, 2021 Tom Murphy and Matthew Perrone, Associated Press

In the weeks since a new Alzheimer’s drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment that has sparked both excitement and skepticism. They want to know […]

Article

REINSTEIN: Short-sighted policies from Washington threaten patients’ hope for innovative new medicines

November 10, 2020 Jay Reinstein

We are currently in a golden age of biopharmaceutical innovation, and scientists are discovering life-changing cures or treatments that were previously unimaginable. For example, the U.S. Food and Drug Administration (FDA) has recently approved the […]

Opinion

Moch: Scientists can beat Alzheimer’s

October 2, 2019 Kenneth Moch

More than 120,000 Americans will lose their battle to Alzheimer’s disease this year. This debilitating condition is the nation’s sixth-leading cause of death. Nationwide, someone in the United States develops Alzheimer’s disease every 65 seconds. […]

Alzheimers

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

Alzheimer’s drug stirs hope for patients, worry for doctors

REINSTEIN: Short-sighted policies from Washington threaten patients’ hope for innovative new medicines

Moch: Scientists can beat Alzheimer’s

House Bill 889 would freeze reappraisals for one year
Property tax moratorium heads to House

House Bill 889 would freeze reappraisals for one year